The firm owns Beta (Systematic Risk) of 0.752 which signifies that as returns on market increase, BHARAT IMMUNOLOGICALS returns are expected to increase less than the market. However during bear market, the loss on holding BHARAT IMMUNOLOGICALS will be expected to be smaller as well. Even though it is essential to pay attention to BHARAT IMMUNOLOGICALS
existing price patterns
, it is always good to be careful when utilizing equity price patterns
. Macroaxis approach to foreseeing future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators
. BHARAT IMMUNOLOGICALS exposes twenty-one different technical indicators which can help you to evaluate its performance. BHARAT IMMUNOLOGICALS
has expected return of -0.1312%. Please be advised to confirm BHARAT IMMUNOLOGICALS BIOLOG Jensen Alpha
, Semi Variance
and the relationship
between Standard Deviation
and Value At Risk
to decide if BHARAT IMMUNOLOGICALS
past performance will be repeated at some future date.
Over the last 30 days BHARAT IMMUNOLOGICALS BIOLOG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
|Fifty Two Week Low||5.75|
|Fifty Two Week High||20.20|